Skip to Main Navigation
Skip to Page Content

Nomination Summary for Cimetidine (N91221)

Nominated Substances: Cimetidine

Nomination Date: 03/11/1991

Nominator: Private Individual

Rationale: This commonly used gastric acid inhibitor appears to increase SCE frequency in ulcer patients and following in-vitro incubation of human lymphocytes. It also produces chromosomal aberrations in rodent models. Inadequate testing for carcinogenicity.

NTP Principles: not specified

Status: In Review/Pending

Agents and Status

The following information relates to the specific agent and may include history from earlier or later nominations for this same agent.

CASRN: 51481-61-9

Agent Name: Cimetidine

  • No studies are available.